22:41 , Jan 19, 2017 |  BC Innovations  |  Finance

IMI branches out

The Innovative Medicines Initiative (IMI) is broadening its base in its latest call for proposals by bringing in funding partners from the non-profit sector. The new partners will add to the portfolio of projects backed...
08:00 , Jan 15, 2015 |  BC Innovations  |  Finance

Consortia cross-talk

There's no doubt that the consortium model is here to stay, but the challenge now is to avoid creating a bureaucracy of committees with duplicate missions and redundancies of effort. The answer might be a...
07:00 , Aug 14, 2014 |  BC Innovations  |  Cover Story

Navigating the new road in psychiatry

The lack of predictive animal models for neuropsychiatric diseases is arguably the biggest single factor stifling drug development in the field. To kick-start discovery for diseases such as autism, schizophrenia and depression, stakeholders will need...
07:00 , Jun 19, 2014 |  BC Innovations  |  Translation in Brief

Translational tidbits

Autism Speaks to Google Patient advocacy group BGI and its subsidiary Complete Genomics Inc. Although obtaining genomic sequences proved relatively cheap and easy, making sense of the sequences proved technically challenging because of the vast...
08:00 , Nov 7, 2013 |  BC Innovations  |  Translation in Brief

Translational tidbits

The Cancer Prevention & Research Institute of Texas is back in the grant-making business after a legislated time-out to rebuild its executive leadership and sort out perceived transparency problems. Last week, Texas Gov. Rick Perry...
07:00 , Oct 24, 2013 |  BC Innovations  |  Strategy

Synaptic synopsis

The early promise that neurotransmitter research would unlock the door for neurological diseases has devolved into sagging interest from several pharmas following repeated failures in clinical trials. Now, genetic findings are pointing to new targets...
07:00 , Oct 14, 2013 |  BC Week In Review  |  Company News

Autism Speaks, Baylor, Boston Children's Hospital, University of California neurology news

Austism Speaks, a non-profit, launched the Preclinical Autism Consortium for Therapeutics (PACT) with autism researchers from Baylor, the Boston Children's Hospital and UC Davis. PACT will build and validate a platform of preclinical tests for...
08:00 , Dec 10, 2012 |  BC Week In Review  |  Company News

Seaside Therapeutics, Autism Speaks neurology news

Autism Speaks and its non-profit venture philanthropy affiliate, Delivering Scientific Innovation for Autism LLC (DELSIA), will provide Seaside with $2 million in funding to discover genetic and protein biomarkers that can identify patients most likely...
07:00 , Oct 29, 2012 |  BC Week In Review  |  Company News

Autism Speaks neurology news

The not-for-profit launched Delivering Scientific Innovation for Autism (DELSIA), a not-for-profit venture philanthropy affiliate that will partner with industry to progress autism research. The partnerships, which will focus on development of drugs, diagnostics and devices,...
07:00 , Aug 13, 2012 |  BC Week In Review  |  Company News

Sigma-Aldrich, Autism Speaks deal

Sigma-Aldrich's Sigma Advanced Genetic Engineering (SAGE) Labs initiative and the advocacy group expanded a 2010 deal to develop rat models with modified autism-associated genes. Under the expansion, the partners will generate rat knockout models with...